Clearline Capital’s Amryt Pharma plc American Depositary Shares AMYT Stock Holding History

Clearline Capital’s Portfolio AMYT Stock Details AMYT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-630,174	Closed	-$9.19M	–	133
2023 Q1	$9.19M	Sell	630,174 -1,768	-0.3%	-$25K	1.39%	24
2022 Q4	$4.61M	Hold	631,942	–	–	0.83%	38
2022 Q3	$4.37M	Hold	631,942	–	–	0.52%	49
2022 Q2	$4.42M	Hold	631,942	–	–	0.57%	44
2022 Q1	$5.23M	Buy	631,942 +31,746	+5%	+$286K	0.6%	37
2021 Q4	$6.48M	Buy	600,196 +94,700	+19%	+$1.02M	0.71%	40
2021 Q3	$6.09M	Buy	+505,496	New	+$5.7M	0.57%	44

Clearline Capital's AMYT Position: Q2 2023 in Review

Clearline Capital sold out of Amryt Pharma plc American Depositary Shares (AMYT) in Q2 2023, closing a stake of 630,174 shares — an estimated $9.19M sold.

Clearline Capital first reported a position in AMYT in Q3 2021 and held it in 7 quarters. The position peaked at $9.19M in Q1 2023. 0 funds tracked by Wall St. Rank hold AMYT as of Q2 2023.

Clearline Capital reported no remaining Amryt Pharma plc American Depositary Shares position as of Q2 2023 after selling out during the quarter.
Clearline Capital sold 630,174 Amryt Pharma plc American Depositary Shares shares in Q2 2023, an estimated $9.19M.
Clearline Capital first reported a position in Amryt Pharma plc American Depositary Shares in Q3 2021 and held it in 7 quarters.
Clearline Capital's Amryt Pharma plc American Depositary Shares position peaked at $9.19M in Q1 2023.
0 funds tracked by Wall St. Rank held Amryt Pharma plc American Depositary Shares as of Q2 2023.

Based on Clearline Capital's 13F filing for Q2 2023, filed 15 Aug 2023.